For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220512:nRSL3441La&default-theme=true
RNS Number : 3441L Mpac Group PLC 12 May 2022
12 May 2022
Mpac Group plc
("Mpac" or the "Company")
Directors/PDMRs Dealing
Notification and public disclosure of transactions by persons discharging
managerial responsibilities ("PDMR") and persons closely associated with them.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Tony Steels
2 Reason for the notification
a) Position/status Chief Executive / PDMR
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Mpac Group plc
b) LEI 213800J3KUDYLRHHU562
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 25p each ("Ordinary Shares")
Identification code GB0005991111
b) Nature of the transaction Transfer of Ordinary shares to Dr Steels by the Mpac Group plc Employee Trust
("Trust") upon exercise of a conditional grant over Ordinary Shares awarded on
1 May 2019 under the Mpac Group plc Deferred Share Plan.
Subsequent sale by Dr Steels of Ordinary Shares back to the Trust to cover the
tax liability arising on exercise.
c) Price(s) and volume(s) (a) In respect of the transfer to Dr Steels:
Volume(s): 35,409 Ordinary Shares
Price: £nil
(b) In respect of the sale by Dr Steels:
Volume(s): 17,085 Ordinary Shares
Price: 470.0 pence per Ordinary Share
d) Aggregated information N/A
- Volume
- Price
- Total
e) Date of the transaction 11 May 2022
f) Place of the transaction Outside a trading venue
Dr Steels shareholding following this transaction is now 128,458 Ordinary
Shares, representing 0.64% of the Company's issued share capital.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name William Wilkins
2 Reason for the notification
a) Position/status Group Finance Director / PDMR
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Mpac Group plc
b) LEI 213800J3KUDYLRHHU562
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 25p each ("Ordinary Shares")
Identification code GB0005991111
b) Nature of the transaction Transfer of Ordinary shares to Mr Wilkins by the Mpac Group plc Employee Trust
("Trust") upon exercise of a conditional grant over Ordinary Shares awarded on
1 May 2019 under the Mpac Group plc Deferred Share Plan.
Subsequent sale by Mr Wilkins of Ordinary Shares back to the Trust to cover
the tax liability arising on exercise.
c) Price(s) and volume(s) (c) In respect of the transfer to Mr Wilkins:
Volume(s): 33,407 Ordinary Shares
Price: £nil
(d) In respect of the sale by Mr Wilkins:
Volume(s): 16,119 Ordinary Shares
Price: 470.0 pence per Ordinary Share
d) Aggregated information N/A
- Volume
- Price
- Total
e) Date of the transaction 11 May 2022
f) Place of the transaction Outside a trading venue
Mr Wilkins shareholding following this transaction is now 23,346 Ordinary
Shares, representing 0.12% of the Company's issued share capital.
For further information, please contact:
Mpac Group plc Tel: +44(0)24 7642 1100
Tony Steels, Chief Executive
Will Wilkins, Group Finance Director
Shore Capital (Nominated Adviser & Broker) Tel: +44(0)20 7408 4050
Advisory
Patrick Castle
Iain Sexton
Broking
Henry Willcocks
Hudson Sandler Tel: +44(0)20 7796 4133
Nick Lyon / Nick Moore
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHDZGMKKZKGZZM